Stay Updated
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation As Some Of The Largest Drug Companies Have Their Day In Court WASHINGTON, D.C. — Oral arguments were presented today in four cases brought by Bristol Myers Squibb (BMS), Johnson & Johnson (J&J), Novartis, and Novo Nordisk […]
Press Releases
STATEMENT: Judge Rejects Another Drug Company Lawsuit Aimed At Blocking Medicare Negotiation
Patients For Affordable Drugs Responds to Judge’s Ruling Against AstraZeneca in The Pharmaceutical Corporation’s Lawsuit Against Medicare Drug Price Negotiation WASHINGTON, D.C. — Today marked a significant moment in the ongoing fight to lower prescription drug prices as a federal judge in Delaware issued a sweeping ruling against AstraZeneca in a case brought by […]
Press Releases
Patients For Affordable Drugs Continues Fight Against Big Pharma’s Attempts To Undermine Medicare Drug Price Negotiation In Landmark Case: AstraZeneca Pharmaceuticals LP et al. v. Becerra et al. WASHINGTON, D.C. — Today marked an important moment in the battle for affordable prescription drugs as oral arguments were presented in the case of AstraZeneca Pharmaceuticals LP […]
Press Releases
Moderna, BioNTech And Pfizer Took Interest Only After The Key Discovery Funded By U.S. Taxpayers Through NIH Patients And All Americans Should Be Getting A Better Deal On Vaccines They Paid To Make Possible WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs […]
Press Releases
Report Update Reveals Drug Industry Funding And Control Of Groups Purporting To Represent Patients
WASHINGTON, D.C. — A new report update of P4AD’s research into drug industry influence – Hiding In Plain Sight – documents the structure and conduct of three organizations that have garnered increased attention recently purporting to represent the interests of patients, but which in reality serve the interests of those who profit from prescription drugs. […]
Press Releases
WASHINGTON, D.C. — A new report by Patients For Affordable Drugs (P4AD) released today unpacks the burden of high priced cancer drugs on patients and details the powerful, positive impact the Inflation Reduction Act will have in the coming years. The report includes new findings on the amount of money saved by traditional Medicare enrollees […]
Press Releases
WASHINGTON, D.C. — The following statement was issued by Merith Basey, executive director of Patients For Affordable Drugs, in response to Eli Lilly and Company’s announcement to lower some of the company’s insulin prices by 70% and cap out-of-pocket costs at $35 per month: “Eli Lilly’s new insulin prices and caps will deliver long-awaited relief […]
Press Releases
ICYMI: Q&A With P4AD’s Executive Director Merith Basey
WASHINGTON, D.C. — Merith Basey, P4AD’s new executive director, fielded questions from P4AD’s patient community in a virtual Q&A yesterday. The forum was moderated by New Jersey patient advocate Lisa Ann Wetzel-Trainor, who lives with PTSD, fibromyalgia, and ADHD, and has been a strong advocate with P4AD for years. Over the past few weeks, patient advocates in 34 states submitted over […]